Delivery Order SPE2DB20D1100-SPE2DB25FE1K8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,983.30 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 20, 2025, with completion expected by August 21, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for $4,418.88 to supply Xulane 150-35 mcg/day transdermal patches (quantity: 3 units). This is a firm fixed price delivery order with no set-aside designation, completed competitively under the company's larger indefinite delivery contract with DLA Troop Support Medical. The order is set to be fulfilled by the ultimate completion date of August 13, 2025, with the place of performance in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Xulane 150-35 mcg/day transdermal patches (3-pack units) with a ceiling value of $6,836.59 under a firm fixed price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at approximately $23.8k to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price, competitively awarded delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,038.24 on August 19, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-pack units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by August 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (three-count units) with a ceiling value of $1,402.17. This firm fixed-price delivery order, which is expected to be completed by August 13, 2025, represents a non-competitive award issued under an existing contract vehicle. The award specifies Conshohocken, Pennsylvania as the place of performance, which aligns with...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.78 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,490.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count package) with a completion date of August 25, 2025. This non-set-aside competitive award represents a direct fulfillment order issued under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,787.52 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate...
- The Defense Logistics Agency awarded a $2,481.92 delivery order to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day patches (three-unit package) under a firm fixed-price contract. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1K8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,320.39 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract serves multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, as part of DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/19/25 |